I-Mab (IMAB)
NASDAQ: IMAB · Real-Time Price · USD
0.923
-0.030 (-3.17%)
At close: Dec 20, 2024, 4:00 PM
0.953
+0.030 (3.27%)
After-hours: Dec 20, 2024, 6:26 PM EST
I-Mab Market Cap
I-Mab has a market cap or net worth of $75.23 million as of December 20, 2024. Its market cap has decreased by -41.90% in one year.
Market Cap
75.23M
Enterprise Value
-105.38M
1-Year Change
-41.90%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $138.05M to $75.23M, a decrease of -45.51%. That is a compound annual growth rate of -11.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 75.23M | -52.29% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | 3.32B | 2,307.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 23andMe Holding Co. | 79.06M |
| Adlai Nortye | 78.97M |
| ALX Oncology Holdings | 78.06M |
| InspireMD | 77.73M |
| Ikena Oncology | 77.70M |
| PMV Pharmaceuticals | 77.62M |
| Quince Therapeutics | 77.44M |
| Theratechnologies | 76.87M |